Ads
related to: negative symptoms of schizophrenia- Side Effects & Benefits
See More Information
See Common Side Effects
- Savings & Support
Pay as Little as $5 per Month
Download Savings Card
- Treatment Information
View Recommended Dosage
Find Local Care Center Near You
- Patient Resources
See How ABILIFY ASIMTUFII® May Help
Download Guide
- Side Effects & Benefits
Search results
Teva and Medincell’s schizophrenia drug meets main goal of late-stage study
KFGO· 6 days ago(Reuters) -Israel-based Teva Pharmaceuticals and French partner Medincell said on Wednesday their...
In Vivo Reactive Astrocyte Imaging in Patients With Schizophrenia Using [18F]THK5351
Journal of the American Medical Association· 5 days agoThis case-control study investigates the in vivo imaging of reactive astrocytes and their association with positive symptoms in patients with schizophrenia
NeuShen begins dosing for Phase I trial of schizophrenia treatment
Clinical Trials Arena via Yahoo Finance· 5 days agoDeveloped from NeuShen’s small molecule R&D platform, NS-136 has shown efficacy against both...
'Impressive' New Data on Novel Schizophrenia Hopeful KarXT
Medscape· 6 days agoThe novel investigational antipsychotic KarXT was effective and well tolerated in adults with ...
...First-in-Human Trial of NS-136, a Novel Selective M4 Receptor Positive Allosteric Modulator for...
NBC 17 Raleigh· 6 days agoM4 PAM presents a novel approach to treating schizophrenia, with potential benefits in alleviating negative symptoms and cognitive impairment ...
Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
Zacks via Yahoo Finance· 5 days agoPipeline Updates In March 2024, Acadia announced the failure of its late-stage study evaluating...
Teva and Medincell report positive data for TEV-‘749 in schizophrenia trial
Clinical Trials Arena via Yahoo Finance· 5 days agoThe Phase III SOLARIS trial has revealed promising results for TEV...The study met its primary...
Cat owners could be at higher risk of schizophrenia, study suggests
FOX 10 Phoenix· 5 days agoThe report, released by researchers from the University of Queensland in Australia, implies that...
Raymond James Cuts HLS Therapeutics (TSE:HLS) Price Target to C$4.00
ETF DAILY NEWS· 21 hours agoHLS Therapeutics (TSE:HLS – Free Report) had its target price cut by Raymond James from C$5.00 to C$4.00 in a report issued on Friday morning, BayStreet.CA reports. A number of other research ...
TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up
Zacks via Yahoo Finance· 4 days agoTEVA reports mixed first-quarter results, missing estimates for earnings but beating the same for...
